CD8A and hepatocellular carcinoma: Several studies have demonstrated that high levels of CD8+ T cell was associated with favorable survival in cancers such as hepatocellular carcinoma, breast cancer, and ovarian cancer (Consortium et al., 2017; Savas et al., 2018; Guo et al., 2020).